RxDoctor Payments Data

Ra'kerry Rahman, MD

Orthopaedic Surgery of the Spine · Houston, TXNPI 1972752228

Payments from drug & device makers

What this record shows

This record is dominated by other: $31,200 of the $44,972 with a category attached, or 69.4%. Orthofix Medical, Inc. accounts for 69.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $32,599, more than ten times the $3,059 reported in 2019.

$44,972in general payments, 2019–2025

Across 119 payments — averaging $377.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$31K
  • Nevro Corp.$2K
  • Boston Scientific$2K
  • Life Spine, Inc.$2K
  • Abbott$1K
  • Globus Medical$1K
  • plus $5K from 20 others
$93,276in research payments, 2019–2025

Across 5 payments — averaging $18,655 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mesoblast, Inc.$93K
$50,000in ownership & investment interests, 2019–2025

Across 4 payments — averaging $12,500 each. An ownership or investment interest held by the physician or an immediate family member.

  • Axiomed LLC$50K

What the payments were for

  • Royalty or licence$1,8534%
  • Travel & lodging$4,98911%
  • Food & beverage$6,93015%
  • Other$31,20069%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,972 in reported general payments places this provider in the 70th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas

Medicare billing

Part B allowed, 2024
$40,618
Medicare patients
71
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$354
Cyclobenzaprine Hcl39$317
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$235
Naproxen31$230
Gabapentin29$223
Tizanidine Hcl22$162
Methylprednisolone23$120
Methocarbamol11$111
Tramadol Hcl11$65
Meloxicam17$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →